Pharmacoresistant Temporal Lobe Epilepsy Controlled by Bilateral Anterior Thalamic Nuclei Thalamotomy

Autori

  • Made Agus Mahendra Inggas Department of Neurosurgery, Faculty of Medicine Universitas Pelita Harapan, Tangerang-Banten
  • Retno Jayantri Ketaren Department of Neurology, Faculty of Medicine Universitas Pelita Harapan, Tangerang-Banten
  • Vivien Puspitasari Department of Neurology, Faculty of Medicine Universitas Pelita Harapan, Tangerang-Banten
  • Julianta Wahyoepramono Department of Neurosurgery, Faculty of Medicine Universitas Pelita Harapan, Tangerang-Banten

##semicolon##

https://doi.org/10.59188/eduvest.v5i1.50815

##semicolon##

Pharmacorsistant epilepsy##common.commaListSeparator## Temporal Lobe Epilepsy##common.commaListSeparator## ATN thalamotomy

Abstrakt

Introduction: Several potential targets have been suggested for the treatment of pharmacoresistant epilepsy, including medial parts of temporal lobes, caudate nucleus, cerebellum, centromedian nucleus of the thalamus, subthalamic nucleus and anterior thalamic nucleus (ATN). The effectiveness of bilateral ATN thalamotomy as treatment option for pharmacoresistant temporal lobe epilepsy is a considerable approach in this recent advances. Method: Case report. Result: A 24-year old male patient presented with unknown onset of generalized tonic clonic seizures and serials of drop attacks since 4 years of age. He was also diagnosed with Attention Defcit Hyperactivity Disorder (ADHD) and a history of febrile seizures. Brain MRI was normal. He has been treated with so many combination of antiepileptic drugs (AEDs) with last combination were Valproic acid 500 mg twice daily, Clonazepam 2 mg thrice daily and Zonisamide 100 mg twice daily. Despite all polytherapy AEDs given, he was still having recurrent seizures. Vagal Nerve Stimulation (VNS) was then conducted and seizures were slightly better. After maximal VNS voltage given, seizures became more frequent. ATN bilateral thalamotomy was done five years after, where seizure was better controlled. Levetiracetam 500mg twice daily and phenobarbital 15 mg once was given in concordance to the surgery, and the patient is doing well until now. Conclusion: In pharmacoresistant temporal lobe epilepsy where AEDs and VNS showed no signifcant improvement, ATN bilateral thalamotomy is considered to be a compelling treatment option. As we know, this is a first case report for ATN thalamotomy for epilepsy in south east asia region.

##submission.citations##

Bahgat, D., Magill, S. T., Berk, C., McCartney, S., & Burchiel, K. J. (2013). Thalamotomy as a treatment option for tremor after ineffective deep brain stimulation. Stereotactic and Functional Neurosurgery, 91(1), 18–23.

Fisher, R. S., Cross, J. H., D’souza, C., French, J. A., Haut, S. R., Higurashi, N., Hirsch, E., Jansen, F. E., Lagae, L., & Moshé, S. L. (2017). Instruction manual for the ILAE 2017 operational classification of seizure types. Epilepsia, 58(4), 531–542.

Gibson, W. S., Ross, E. K., Han, S. R., Van Gompel, J. J., Min, H.-K., & Lee, K. H. (2016). Anterior thalamic deep brain stimulation: functional activation patterns in a large animal model. Brain Stimulation, 9(5), 770–773.

Huff, J. S., & Fountain, N. B. (2011). Pathophysiology and definitions of seizures and status epilepticus. Emergency Medicine Clinics, 29(1), 1–13.

Morgan, V. L., Rogers, B. P., & Abou‐Khalil, B. (2015). Segmentation of the thalamus based on BOLD frequencies affected in temporal lobe epilepsy. Epilepsia, 56(11), 1819–1827.

Ngugi, A. K., Bottomley, C., Kleinschmidt, I., Sander, J. W., & Newton, C. R. (2010). Estimation of the burden of active and life‐time epilepsy: a meta‐analytic approach. Epilepsia, 51(5), 883–890.

Shorvon, S. D., Andermann, F., & Guerrini, R. (2011). The causes of epilepsy: common and uncommon causes in adults and children. Cambridge University Press.

Sillanpää, M., & Shinnar, S. (2010). Long-term mortality in childhood-onset epilepsy. New England Journal of Medicine, 363(26), 2522–2529.

Sitnikov, A. R., Grigoryan, Y. A., & Mishnyakova, L. P. (2018). Bilateral stereotactic lesions and chronic stimulation of the anterior thalamic nuclei for treatment of pharmacoresistant epilepsy. Surgical Neurology International, 9.

Sweeney-Reed, C. M., Lee, H., Rampp, S., Zaehle, T., Buentjen, L., Voges, J., Holtkamp, M., Hinrichs, H., Heinze, H.-J., & Schmitt, F. C. (2016). Thalamic interictal epileptiform discharges in deep brain stimulated epilepsy patients. Journal of Neurology, 263, 2120–2126.

Tamber, M. S., & Mountz, J. M. (2012). Advances in the diagnosis and treatment of epilepsy. Seminars in Nuclear Medicine, 42(6), 371–386.

Tatum IV, W. O. (2012). Mesial temporal lobe epilepsy. Journal of Clinical Neurophysiology, 29(5), 356–365.

Téllez-Zenteno, J. F., & Hernández-Ronquillo, L. (2012). A review of the epidemiology of temporal lobe epilepsy. Epilepsy Research and Treatment, 2012(1), 630853.

Van Gompel, J. J., Klassen, B. T., Worrell, G. A., Lee, K. H., Shin, C., Zhao, C. Z., Brown, D. A., Goerss, S. J., Kall, B. A., & Stead, M. (2015). Anterior nuclear deep brain stimulation guided by concordant hippocampal recording. Neurosurgical Focus, 38(6), E9.

##submission.downloads##

Publikované

2025-01-20

Najaktuálnejšie články rovnakého autora (rovnakých autorov)